Day-to-day and multicenter reproducibility of quantitating malignant myeloma cells using real-time IgH ASO-PCR or a limiting dilution assay
Patient . | Center . | Quantitation method . | No.analyses . | Type of variation . | Input tumor cells (no.) . | Calculated tumor cells (no.) . | ASO-PCR variation . | Control PCR variation . | Total variation . | Average per patient . | Average total . |
---|---|---|---|---|---|---|---|---|---|---|---|
Variation coefficient | |||||||||||
6 | E | Limiting dilution | 3 | Day-to-day | 9.6 | 10.1 | 0.24 | 0.56 | 0.61 | ||
6 | C | Limiting dilution | 3 | Day-to-day | 9.6 | 13.7 | 0.32 | 0.92 | 0.97 | ||
6 | A | Real time PCR | 4 | Day-to-day | 9.6 | 12.6 | 0.15 | 0.26 | 0.30 | ||
6 | E, C, G, U | Limiting dilution | Single | Multicenter (4) | 9.6 | 11 | 0.24 | 0.72 | 0.76 | ||
6 | E, C, G, U | Limiting dilution | Triplo 5 | Multicenter (4) | 9.6 | 10.7 | 0.11 | 0.44 | 0.45 | ||
6 | E | Limiting dilution | 3 | Day-to-day | 1600 | 2306 | 0.09 | 1.04 | 1.04 | 0.83 | |
6 | C | Limiting dilution | 3 | Day-to-day | 1600 | 695 | 0.65 | 0.84 | 1.06 | 1.02 | |
6 | A | Real-time PCR | 4 | Day-to-day | 1600 | 1890 | 0.32 | 0.14 | 0.35 | 0.33 | |
6 | E, C, G, U | Limiting dilution | Single | Multicenter (4) | 1608 | 1287 | 0.50 | 0.89 | 1.02 | 0.89 | |
6 | E, C, G, U | Limiting dilution | Triplo 5 | Multicenter (4) | 1608 | 1701 | 0.45 | 0.49 | 0.67 | 0.56 | |
H | E | Limiting dilution | 3 | Day-to-day | 56 | 54 | 0.64 | 0.49 | 0.81 | ||
H | C | Limiting dilution | 3 | Day-to-day | 56 | 26 | 0.28 | 0.22 | 0.36 | ||
H | A | Real-time PCR | 4 | Day-to-day | 56 | 33 | 0.46 | 0.14 | 0.48 | ||
H | E, C, G, U | Limiting dilution | Single | Multicenter (4) | 56 | 45 | 0.73 | 0.50 | 0.89 | ||
H | E, C, G, U | Limiting dilution | Triplo 5 | Multicenter (4) | 56 | 45 | 0.55 | 0.37 | 0.66 | ||
H | E | Limiting dilution | 3 | Day-to-day | 560 | 866 | 0.40 | 0.33 | 0.52 | 0.67 | 0.75 |
H | C | Limiting dilution | 3 | Day-to-day | 560 | 956 | 0.56 | 0.04 | 0.56 | 0.46 | 0.74 |
H | A | Real-time PCR | 4 | Day-to-day | 560 | 1702 | 0.27 | 0.10 | 0.29 | 0.39 | 0.36 |
H | E, C, G, U | Limiting dilution | Single | Multicenter (4) | 560 | 993 | 0.43 | 0.44 | 0.62 | 0.76 | 0.83 |
H | E, C, G, U | Limiting dilution | Triplo 5 | Multicenter (4) | 560 | 990 | 0.34 | 0.44 | 0.56 | 0.61 | 0.59 |
Patient . | Center . | Quantitation method . | No.analyses . | Type of variation . | Input tumor cells (no.) . | Calculated tumor cells (no.) . | ASO-PCR variation . | Control PCR variation . | Total variation . | Average per patient . | Average total . |
---|---|---|---|---|---|---|---|---|---|---|---|
Variation coefficient | |||||||||||
6 | E | Limiting dilution | 3 | Day-to-day | 9.6 | 10.1 | 0.24 | 0.56 | 0.61 | ||
6 | C | Limiting dilution | 3 | Day-to-day | 9.6 | 13.7 | 0.32 | 0.92 | 0.97 | ||
6 | A | Real time PCR | 4 | Day-to-day | 9.6 | 12.6 | 0.15 | 0.26 | 0.30 | ||
6 | E, C, G, U | Limiting dilution | Single | Multicenter (4) | 9.6 | 11 | 0.24 | 0.72 | 0.76 | ||
6 | E, C, G, U | Limiting dilution | Triplo 5 | Multicenter (4) | 9.6 | 10.7 | 0.11 | 0.44 | 0.45 | ||
6 | E | Limiting dilution | 3 | Day-to-day | 1600 | 2306 | 0.09 | 1.04 | 1.04 | 0.83 | |
6 | C | Limiting dilution | 3 | Day-to-day | 1600 | 695 | 0.65 | 0.84 | 1.06 | 1.02 | |
6 | A | Real-time PCR | 4 | Day-to-day | 1600 | 1890 | 0.32 | 0.14 | 0.35 | 0.33 | |
6 | E, C, G, U | Limiting dilution | Single | Multicenter (4) | 1608 | 1287 | 0.50 | 0.89 | 1.02 | 0.89 | |
6 | E, C, G, U | Limiting dilution | Triplo 5 | Multicenter (4) | 1608 | 1701 | 0.45 | 0.49 | 0.67 | 0.56 | |
H | E | Limiting dilution | 3 | Day-to-day | 56 | 54 | 0.64 | 0.49 | 0.81 | ||
H | C | Limiting dilution | 3 | Day-to-day | 56 | 26 | 0.28 | 0.22 | 0.36 | ||
H | A | Real-time PCR | 4 | Day-to-day | 56 | 33 | 0.46 | 0.14 | 0.48 | ||
H | E, C, G, U | Limiting dilution | Single | Multicenter (4) | 56 | 45 | 0.73 | 0.50 | 0.89 | ||
H | E, C, G, U | Limiting dilution | Triplo 5 | Multicenter (4) | 56 | 45 | 0.55 | 0.37 | 0.66 | ||
H | E | Limiting dilution | 3 | Day-to-day | 560 | 866 | 0.40 | 0.33 | 0.52 | 0.67 | 0.75 |
H | C | Limiting dilution | 3 | Day-to-day | 560 | 956 | 0.56 | 0.04 | 0.56 | 0.46 | 0.74 |
H | A | Real-time PCR | 4 | Day-to-day | 560 | 1702 | 0.27 | 0.10 | 0.29 | 0.39 | 0.36 |
H | E, C, G, U | Limiting dilution | Single | Multicenter (4) | 560 | 993 | 0.43 | 0.44 | 0.62 | 0.76 | 0.83 |
H | E, C, G, U | Limiting dilution | Triplo 5 | Multicenter (4) | 560 | 990 | 0.34 | 0.44 | 0.56 | 0.61 | 0.59 |
The factor-range expresses the quotient of actual maximal and minimal values found in the quantitation assays.
Triplo 5, mean of 5 PCR reactions; whole procedure is repeated 3 times (15 PCR).